Actemra® is an IL-6 receptor antagonist used to treat conditions involving systemic inflammation. It is commonly administered via IV for Rheumatoid Arthritis and Giant Cell Arteritis.
therapies we administer
Conditions Treated
- Rheumatoid Arthritis (RA)
- Giant Cell Arteritis (GCA)
How It Works
Actemra® blocks interleukin-6 (IL-6), a cytokine involved in inflammation. By inhibiting IL-6 signaling, it helps reduce pain, stiffness, and long-term joint damage.
Infusion Schedule & Duration
- Frequency: Every 4 weeks
- Infusion Time: 60 minutes
- Pre-meds: Generally not required
What to Expect
- Lab monitoring before and during treatment
- Supportive care during infusion
- Post-infusion check-ins coordinated with your provider
Potential Side Effects
- Upper respiratory infections
- Elevated liver enzymes
- Headaches
GET IN TOUCH
Referrals & Insurance
Requires a referral from a licensed physician. Prior authorization may be necessary.